|
1
|
Białecka-Florjańczyk E, Fabiszewska A and Zieniuk B: Phenolic acids derivatives - biotechnological methods of synthesis and bioactivity. Curr Pharm Biotechnol. 19:1098–1113. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kumar N and Goel N: Phenolic acids: Natural versatile molecules with promising therapeutic applications. Biotechnol Rep (Amst). 24(pe00370)2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Nwidu LL, Nwafor PA, da Silva VC, Rodrigues CM, dos Santos LC, Vilegas W and Nunes-de-Souza RL: Anti-nociceptive effects of Carpolobia lutea G. Don (Polygalaceae) leaf fractions in animal models. Inflammopharmacology. 19:215–225. 2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Nwidu LL, Essien GE, Nwafor PA and Vilegas W: Antidiarrheal mechanism of Carpolobia lutea leaf fractions in rats. Pharm Biol. 49:1249–1256. 2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
El-Seedi HR, El-Said AM, Khalifa SA, Göransson U, Bohlin L, Borg-Karlson AK and Verpoorte R: Biosynthesis, natural sources, dietary intake, pharmacokinetic properties, and biological activities of hydroxycinnamic acids. J Agric Food Chem. 60:10877–10895. 2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Pei K, Ou J, Huang J and Ou S: p-Coumaric acid and its conjugates: Dietary sources, pharmacokinetic properties and biological activities. J Sci Food Agric. 96:2952–2962. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Hong SY, Jeong WS and Jun M: Protective effects of the key compounds isolated from Corni fructus against β-amyloid-induced neurotoxicity in PC12 cells. Molecules. 17:10831–10845. 2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Piñeiro-Carrero VM and Piñeiro EO: Liver. Pediatrics. 113 (Suppl 4):1097–1106. 2004.PubMed/NCBI
|
|
9
|
Upcroft P and Upcroft JA: Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin Microbiol Rev. 14:150–164. 2001.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Parvizi F, Yaghmaei P, Haeri Rohani SA and Mard SA: Hepatoprotective properties of p-coumaric acid in a rat model of ischemia-reperfusion. Avicenna J Phytomed. 10:633–640. 2020.PubMed/NCBI
|
|
11
|
Ekinci Akdemir FN, Albayrak M, Çalik M, Bayir Y and Gülçin İ: The protective effects of p-coumaric acid on acute liver and kidney damages induced by cisplatin. Biomedicines. 5(E18)2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Frank D, Savir S, Gruenbaum BF, Melamed I, Grinshpun J, Kuts R, Knyazer B, Zlotnik A, Vinokur M and Boyko M: Inducing acute liver injury in rats via carbon tetrachloride (CCl4) exposure through an orogastric tube. J Vis Exp: Apr 28, 2020 (Epub ahead of print). doi: 10.3791/60695.
|
|
13
|
Van Campenhout S, Van Vlierberghe H and Devisscher L: Common bile duct ligation as model for secondary biliary cirrhosis. Methods Mol Biol. 1981:237–247. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Georgiev P, Jochum W, Heinrich S, Jang JH, Nocito A, Dahm F and Clavien PA: Characterization of time-related changes after experimental bile duct ligation. Br J Surg. 95:646–656. 2008.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Reitman S and Frankel S: A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol. 28:56–63. 1957.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Glossmann H and Neville DM: gamma-glutamyltransferase in kidney brush border membranes. FEBS Lett. 19:340–344. 1972.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Bergmeyer HU, Grabl M and Walter HE: Enzymes. In: Methods of Enzymatic Analysis, a.M.G.V.-C.W. Bergmeyer J (ed), pp269-270, 1983.
|
|
18
|
Luna LG: Manual of Histologic Staining Methods of the Arme Forces Institute of Pathology. 3rd edition. McGraw-Hill, New York, NY, 1968.
|
|
19
|
Diamond LS, Harlow DR and Cunnick CC: A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg. 72:431–432. 1978.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Strober W: Trypan blue exclusion test of cell viability. Curr Protoc Immunol: May 1, 2015 (Epub ahead of print). doi: 10.1002/0471142735.ima03bs21.
|
|
21
|
Li S, Tan HY, Wang N, Zhang ZJ, Lao L, Wong CW and Feng Y: The role of oxidative stress and antioxidants in liver diseases. Int J Mol Sci. 16:26087–26124. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Sun M and Kisseleva T: Reversibility of liver fibrosis. Clin Res Hepatol Gastroenterol. 39 (Suppl 1):S60–S63. 2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Luedde T, Kaplowitz N and Schwabe RF: Cell death and cell death responses in liver disease: Mechanisms and clinical relevance. Gastroenterology. 147:765–783.e4. 2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kanduc D, Mittelman A, Serpico R, Sinigaglia E, Sinha AA, Natale C, Santacroce R, Di Corcia MG, Lucchese A, Dini L, et al: Cell death: Apoptosis versus necrosis (Review). Int J Oncol. 21:165–170. 2002.PubMed/NCBI
|
|
25
|
Boll M, Weber LW, Becker E and Stampfl A: Mechanism of carbon tetrachloride-induced hepatotoxicity. Hepatocellular damage by reactive carbon tetrachloride metabolites. Z Naturforsch C J Biosci. 56:649–659. 2001.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Deniz GY, Laloglu E, Koc K, Nadaroglu H and Geyikoglu F: The effect of black mulberry (Morus nigra) extract on carbon tetrachloride-induced liver damage. Arch Biol Sci. 70:371–378. 2018.
|
|
27
|
Sokol RJ, Devereaux M, Dahl R and Gumpricht E: ‘Let there be bile’ - understanding hepatic injury in cholestasis. J Pediatr Gastroenterol Nutr. 43 (Suppl 1):S4–S9. 2006.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Cha H, Lee S, Lee JH and Park JW: Protective effects of p-coumaric acid against acetaminophen-induced hepatotoxicity in mice. Food Chem Toxicol. 121:131–139. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Li M, Cai SY and Boyer JL: Mechanisms of bile acid mediated inflammation in the liver. Mol Aspects Med. 56:45–53. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Mariotti V, Cadamuro M, Spirli C, Fiorotto R, Strazzabosco M and Fabris L: Animal models of cholestasis: An update on inflammatory cholangiopathies. Biochim Biophys Acta Mol Basis Dis. 1865:954–964. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Glaser SS, Onori P, Wise C, Yang F, Marzioni M, Alvaro D, Franchitto A, Mancinelli R, Alpini G, Munshi MK, et al: Recent advances in the regulation of cholangiocyte proliferation and function during extrahepatic cholestasis. Dig Liver Dis. 42:245–252. 2010.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Chou A and Austin RL: Entamoeba Histolytica. StatPearl, Treasure Island, FL, 2021.
|
|
33
|
Zulfiqar H, Mathew G and Horrall S: Amebiasis. StatPearls, Treasure Island, FL, 2021.
|
|
34
|
Kantor M, Abrantes A, Estevez A, Schiller A, Torrent J, Gascon J, Hernandez R and Ochner C: Entamoeba Histolytica: Updates in Clinical Manifestation, Pathogenesis, and Vaccine Development. Can J Gastroenterol Hepatol. 2018(4601420)2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Wassmann C, Hellberg A, Tannich E and Bruchhaus I: Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase. J Biol Chem. 274:26051–26056. 1999.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Degerli S and Tepe B: Phenolic acid composition and anti-parasitic effects of four peucedanum species on Entamoeba histolytica Trophozoites. Iran J Parasitol. 10:420–431. 2015.PubMed/NCBI
|
